A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.
BACKGROUND:Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low...
Príomhchruthaitheoirí: | , , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Public Library of Science (PLoS)
2016-01-01
|
Sraith: | PLoS ONE |
Rochtain ar líne: | http://europepmc.org/articles/PMC4732739?pdf=render |